Tag: Aravinda de Silva

Zika virus (ZIKV) caused unprecedented outbreaks in South America and the Caribbean in 2015–2016, leading primarily to a series of abnormalities in neonates termed congenital Zika syndrome. The threat of ZIKV reemergence has seen the development of multiple ZIKV vaccines that are at the preclinical stage or in early-stage clinical...

Aravinda de Silva, PhD, MPH, a member of the Institute for Global Health and Infectious Diseases, has designed a new blood test to accurately diagnose dengue and Zika Viruses, to improve surveillance and advance vaccine development. The dengue virus (DENV), which infects several hundred million people worldwide each year, is responsible...

  Researchers within UNC’s School of Medicine are working tirelessly to provide knowledge to impact the current COVID-19 pandemic and future pandemics. “UNC SOM is home to many world-renowned experts on infectious disease and virology,” says Blossom Damania, Boshamer Distinguished Professor and Vice Dean for Research at the UNC School...